🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Uppsala-Dalarna Dementia and Gait Project

Recruitingn/aAges 37 Years - 94 YearsAllDalarna University
NCT05893524 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

UDDGait™ is a multidisciplinary research project with the overreaching goal of providing an aid for early identification of cognitive impairment and risk of dementia development, thereby providing a basis for adequate symptom relieving and health promoting interventions. A new concept is investigated for this purpose: a "dual-task-test", which implies the combination of a well-established mobility test (Timed Up-and-Go, TUG) with a simultaneous verbal task (i.e. TUG dual-task, TUGdt). This type of test has been judged as a potential aid for early identification of dementia disease. More research is needed to further examine the test's validity, reliability and predictive capacity. The overall aim is to investigate if TUGdt is useful as an aid for prediction of dementia disease. To ensure the results, the aim is also to evaluate the test's measurement properties and to generate normativ

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients undergoing memory assessment at at Uppsala University Hospital, Sweden * Patients undergoing memory assessment at at Falu Hospital, Sweden * Cognitively unimpaired individuals with a Mini Mental State Examination (MMSE) score of \> 26 Exclusion Criteria: * Inability to walk three meters back and forth * Inability to rise from a sitting position * Indoor use of a walking aid * Current or recent hospitalization (within the last 2 weeks) * Need of an interpreter to communicate in Swedish
💊

What it tests

  • Timed Up-and-Go (TUG single-task)
  • Timed Up-and-Go dual-task (TUGdt)
  • Clinical functional assessment
📍

Where

2 sites
Dalarna University
Falun, Sweden
Uppsala University
Uppsala, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy